ArticleVirchows Archiv : an international journal of pathology2026
Granulomatous prostatitis as a cause of elevated PI-RADS scores on multiparametric MRI: insights from a single institution cohort.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granulomatous prostatitis (GP) frequently mimics prostatic adenocarcinoma on multiparametric MRI (mpMRI), producing elevated PI-RADS scores and diagnostic challenges. We retrospectively analyzed 63 patients with biopsy-proven GP (without concurrent prostate cancer) and paired mpMRI (2019-2025) to correlate radiologic and histopathologic findings. Median age was 66 years (range 41-80), median PSA 6.2 ng/mL (range 0.1-26.4), and median percentage of biopsy parts involved (PPI) was 36% (range 6-100%). PI-RADS distribution: 2 (14%), 3 (22%), 4 (24%), 5 (40%). High PI-RADS scores (4-5, n = 40, 63%) correlated with higher median PPI (48% vs. 17%, p = 0.01) vs. low PI-RADS scores (2-3, n = 23, 37%), but not PSA (6.4 vs. 5.3 ng/mL, p = 0.68). Among high PI-RADS cases, 25% had prior BCG therapy. One patient with sarcoidosis presented with PI-RADS 5 and 93% PPI. GP produces a broad PI-RADS spectrum; recognizing this imaging variability is essential for accurate diagnosis and avoiding unnecessary procedures.
Indexed as
Identifiers
42249094What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.